CalciMedica (CALC) Stock Forecast, Price Target & Predictions
CALC Stock Forecast
CalciMedica stock forecast is as follows: an average price target of $266.00 (represents a 7840.30% upside from CALC’s last price of $3.35) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CALC Price Target
The average price target for CalciMedica (CALC) is $266.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $392.00 to $14.00. This represents a potential 7840.30% upside from CALC's last price of $3.35.
CALC Analyst Ratings
According to 3 Wall Street analysts, CalciMedica's rating consensus is 'Buy'. The analyst rating breakdown for CALC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
CalciMedica Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 20, 2024 | Leland Gershall | Oppenheimer | $14.00 | $5.45 | 156.88% | 317.91% |
| Nov 22, 2022 | Christopher Raymond | Raymond James | $392.00 | $146.90 | 166.84% | 11601.49% |
| May 18, 2022 | Christopher Raymond | Piper Sandler | $392.00 | $171.81 | 128.15% | 11601.49% |
The latest CalciMedica stock forecast, released on May 20, 2024 by Leland Gershall from Oppenheimer, set a price target of $14.00, which represents a 156.88% increase from the stock price at the time of the forecast ($5.45), and a 317.91% increase from CALC last price ($3.35).
CalciMedica Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $14.00 |
| Last Closing Price | $3.35 | $3.35 | $3.35 |
| Upside/Downside | -100.00% | -100.00% | 317.91% |
In the current month, the average price target of CalciMedica stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CalciMedica's last price of $3.35. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 28, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Jun 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 20, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| May 18, 2022 | Piper Sandler | Neutral | Neutral | Hold |
CalciMedica's last stock rating was published by Oppenheimer on Jun 28, 2024. The company gave CALC a "Outperform" rating, the same as its previous rate.
CalciMedica Financial Forecast
CalciMedica Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Avg Forecast | $100.00M | - | - | - | - | - | - | $75.00K |
| High Forecast | $100.00M | - | - | - | - | - | - | $75.00K |
| Low Forecast | $100.00M | - | - | - | - | - | - | $75.00K |
| # Analysts | 1 | - | - | - | - | - | - | 1 |
| Surprise % | - | - | - | - | - | - | - | - |
CalciMedica's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CALC's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
CalciMedica EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | - | - | - | - | - | - | 1 |
| EBITDA | - | - | - | - | - | - | - | $-10.06M |
| Avg Forecast | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - |
undefined analysts predict CALC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CalciMedica's previous annual EBITDA (undefined) of $NaN.
CalciMedica Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | - | - | - | - | - | - | 1 |
| Net Income | - | - | - | - | - | - | - | $-10.15M |
| Avg Forecast | $8.52M | $-5.68M | $-4.12M | $-4.01M | $-4.90M | $-6.26M | $-6.39M | $-59.52M |
| High Forecast | $8.52M | $-5.68M | $-4.12M | $-3.05M | $-3.67M | $-6.26M | $-6.39M | $-59.52M |
| Low Forecast | $8.52M | $-5.68M | $-4.12M | $-4.97M | $-6.12M | $-6.26M | $-6.39M | $-59.52M |
| Surprise % | - | - | - | - | - | - | - | 0.17% |
CalciMedica's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CALC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
CalciMedica SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | - | - | - | - | - | - | 1 |
| SG&A | - | - | - | - | - | - | - | $4.13M |
| Avg Forecast | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - |
CalciMedica's average Quarter SG&A projection for Jun 24 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to CALC last annual SG&A of $4.13M (Mar 22).
CalciMedica EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | - | - | - | - | - | - | 1 |
| EPS | - | - | - | - | - | - | - | $-1.81K |
| Avg Forecast | $0.77 | $-0.51 | $-0.37 | $-0.36 | $-0.44 | $-0.56 | $-0.57 | $-5.35 |
| High Forecast | $0.77 | $-0.51 | $-0.37 | $-0.27 | $-0.33 | $-0.56 | $-0.57 | $-5.35 |
| Low Forecast | $0.77 | $-0.51 | $-0.37 | $-0.45 | $-0.55 | $-0.56 | $-0.57 | $-5.35 |
| Surprise % | - | - | - | - | - | - | - | 337.79% |
According to undefined Wall Street analysts, CalciMedica's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CALC previous annual EPS of $NaN (undefined).